SUMMARY One hundred and eighty-four cases of malignant melanoma of the lids and epibulbar region were seen in the Radiotherapy Department of the Royal Marsden Hospital during the period 1943-74. Some of these tumours were radiosensitive and could thus be treated by radiotherapy without loss of the affected eye. Their clinical and histological features are described. The treatment policy adopted was based on radiotherapy first, and surgery reserved for the failures. A policy of observation is advised for precancerous melanosis, and active treatment should be undertaken only if malignancy supervenes. The contraindications for radiotherapy, the factors governing radiosensitivity, and the incidence and site of metastases are reported, and the possible effect on the metastatic and survival rates of leaving the eye are discussed. Active treatment of the node-free neck is not advised. Results are given according to site, histology, and treatment method, and the frequency with which the eye was lost is shown, since the sole advantage of radiotherapy over surgery is the possibility of saving the eye without worsening the prognosis for survival.
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Histological studies largely undertaken in the past decade have greatly increased our knowledge of the cutaneous malignant melanoma. This tumour, which hitherto appeared to be both incomprehensible histogenetically and unpredictable in behaviour, has as a result become more understandable, though much still remains to be discovered. Unfortunately the conclusions drawn by dermatopathologists are not generally accepted by ophthalmic pathologists, and the pathology and treatment of conjunctival malignant melanoma still present unresolved problems, which have been admirably surveyed by Jacobiec. ' Despite advances made in the knowledge of the natural history of malignant melanoma there is still no general agreement on a treatment policy. Surgery understandably dominates treatment, but this dominance is largely based on fear and the laudable desire to rid the patient promptly of a tumour of evil repute. Meanwhile the therapeutic value of radiotherapy remains disputed, the malignant melanoma being customarily regarded as a radioresistant tumour and radiotherapy therefore held to be useless, if not harmful.
It must be conceded that the history of radiotherapy in ophthalmology is an unhappy one. The early attempts to use radiant energy in the treatment of eye diseases were so calamitous that its use in the neighbourhood of the eye is regarded with trepidation to this day. However, with modern equipment and an adequate knowledge of the effects and risks of irradiating the eye it is possible to irradiate malignant tumours of the lids and epib;ulbar region without gross damage and still leave a useful functioning eye. The reluctance of ophthalmologists to use radiotherapy as an alternative to surgery in the treatment of epibulbar malignant melanoma is amply borne out by the infrequency with which this method receives, other than cursory or unfavourable, mention in ophthalmic literature. In this connection it is worth noting that in the third and last edition of Reese's classical work Tumours of the eye2 the treatment of conjunctival malignant melanoma by radiotherapy is not mentioned either in the chapter on pigmented tumours or in the one on radiotherapy.
The purpose of this paper is to try to assess the value and place of radiotherapy in the treatment of these tumours, whose rarity is generally recognised. Reese' stated that he had seen a total of 145 cases in 30 years. Bernadino, Naidoff, and Clark4 could obtain only 23 cases for review from over 20 ophthalmolo-605 The following account contains observations on the clinical material with special reference to the natural history of these tumours, the indications for, and the results and complications of, radiation treatment.
The term epibulbar as used here includes: (1) the palpebral and bulbar conjunctivae, the fornices, and the plica semilunaris; (2) the cornea and the limbus; (3) the cutaneous surface of the lids, the caruncle, and the intermarginal strip. Table 1 lists some of the main features of the clinical material seen. The subdivision of the material into three main sites is in accordance with the differences in their natural history and is also of importance in the selection of radiotherapy technique.
In addition to cancerous melanosis precancerous melanosis in both its premalignant and malignant forms has been included and listed separately so as to facilitate subsequent discussion.
The higher incidence of melanoma of the limbus and conjunctiva among women and the relatively long duration of symptoms is well shown. The probable reason for the small number of lid melanomata was that they were dealt with surgically and were not referred for radiotherapy, since presumably the operations employed did not entail loss of the eye.
The histological classification used in previous reports78 has been retained in spite of the changes in nomenclature in the past decade. The terms precancerous and cancerous melanosis employed by Reese' have been retained, and no doubt included among these cases are the lentigo malignant melanoma and the superficial cicatrising melanoma. The satisfactory identification of these latter tumours is even now not always practicable where the conjunctiva is concerned,' so no attempt has been made to try to identify these two tumour varieties retrospectively.
As this material is essentially a selected one, the basis of selection being the need for radiotherapy, it cannot be used for the reliable assessment of the frequency with which the differing histological types of malignant conjunctival melanoma occur. However, Though we do not enter into the controversy that still exists concerning the origin of the epibulbar malignant melanoma, it should be noted that Reese' estimates that one-quarter ofconj unctival melanomas arise from a pre-existing naevus, one-quarter de novo, and one-half from an acquired melanosis, a term suggested by Zimmerman' to replace the terms precancerous and cancerous melanosis. Zimmerman estimated that one-half of conjunctival melanomas arise de novo, and of the remaining 50% twice as many arise from naevi as from acquired melanosis.
From Table 1 There appears to be a gradient of sensitivity varying from the limbus across the conjunctiva of the globe and fornices to the cutaneous surface of the lids. As a rule the nearer the tumour lies to the limbus the more radiosensitive it is and the better the prognosis with radiotherapy. Tumours of the cutaneous aspect of the lid are the least radiosensitive and usually resemble other skin melanomata in their response. Precancerous and cancerous melanosis, which are essentially multicentric lesions potentially affecting the whole conjunctival sac, are generally radiosensitive, but extensive involvement of the lids in the melanomatous process impairs the prognosis following radiotherapy. The diminution of radiosensitivity when the lid is affected can be explained by the change in character of the tumour bed. The bulbar conjunctiva is lax and mobile and related to a submucous layer, features favouring radiosensitivity, whereas the palpebral conjunctiva is adherent to the dense fibrous tarsal plates, which resemble to a lesser degree the fibrocartilaginous supporting structures of the epiglottis and pinna in their unfavourable influence on radiation response.
MACROSCOPIC APPEARANCES
Flat plaque-like lesions tend to respond slowly to radiation, and the more proliferative the tumour the prompter is the response. The degree ofpigmentation is also of importance. A moderately pigmented patch near the limbus may disappear after radiotherapy, whereas a densely pigmented lesion affecting the fornices and lids may show only a limited response and may persist in an apparently harmless fashion for some time. A clear appreciation of the significance of pigmentation in relation both to neoplasia and to radiation treatment is essential. Pigment as such is merely an index of the metabolic activity of the melanocytes and need not necessarily form an integral part of the tumour. After radiation treatment it is by no means uncommon to see the tumorous element disappear and some pigment remain only to disappear at a much later date. The radiotherapist's aim is therefore not to try to depigment the eye but to achieve total disappearance of the tumour. Pigmentation if persistent and unaccompanied by tumour formation is not as a rule an indication for any active measures.
MICROSCOPIC APPEARANCES
The term malignant melanoma includes a variety of neoplasms differing in aetiology and natural history and prognosis, and not surprisingly a difference in radiosensitivity is encountered among the histological varieties listed in Table 1 .
(a) It is difficult accurately to assess the true radiosensitivity of the malignant melanoma of naevus origin, since in this series wide surgical excision was performed as a preliminary in all the lid cases. However, the surgery employed for the limbal and conjunctival melomata was often merely a biopsy, and any satisfactory result obtained must be attributed mainly to the postoperative radiotherapy.
(b) The malignant melanomata arising de novo without an apparent relationship to a pre-existing mole or precancerous melanosis have nearly all proved highly radiosensitive but not necessarily radiocurable.
(c) Cancerous melanosis is in general a radiosensitive tumour, but there are variations in sensitivity, and careful selection of patients for radiotherapy is necessary. As a rule the flat, densely pigmented lesion showing extensive involvement of the fornices and lids is the least satisfactory type of tumour to treat by The recognition of the malignant potentialities of precancerous melanosis presents the clinician with a difficult therapeutic problem. When the pathologist labels a conjunctival tumour 'malignant melanoma' some form of active treatment must be offered to the patient as a matter of urgency. When, however, the histological diagnosis of precancerous melanosis is made, the clinician is forced into the situation of having to consider treatment for a condition which, without being malignant at the time of diagnosis, may become malignant at some unspecified time in the future, probably 5-10 years according to Reese,2 but in a rather shorter time in our experience ( Table 2) .
The policy to be adopted as regards treatment in these circumstances must depend on: (a) the clinical interpretation of the term 'precancerous'; (b) the clinical assessment of the relative risks to the patient and the eye, (i) if surgical or radiation treatment is undertaken, (ii) if nothing is done and a policy of observation is adopted. THE Cases not coming within these categories may be safely kept under regular observation and any changes assessed on clinical grounds. A biopsy should be performed if any doubt arises. Because of the relative benignity of the lesion routine biopsy is not essential to establish the diagnosis, nor is repeated biopsy necessary to determine progress. In this connection Zimmerman9 also expressed the opinion that in the absence of nodularity or thickening biopsy is not essential. Table 3 illustrates the results of this policy of (6) Of 146 cases (74 cancerous melanosis and 72 malignant melanoma) 9 patients had the eye removed either before referral or as an alternative to radiotherapy. Of the remaining 137 patients (69 cancerous melanosis and 68 malignant melanoma) all treated by radiotherapy 36 patients (approximately 25%) lost the eye, but of these in only 12 cases (9%) could this loss be attributed to radiation damage alone.
The added risk of using y radiation is shown by the fact that the eye was removed for radiation damage in eight of 69 patients (11-6%) with cancerous melanosis where the whole conjunctival sac was treated by y radiation as opposed to four of 68 of the malignant melanoma patients (5.8%) where ( orx radiation was applied to localised areas of the conjunctival sac.
METASTASES
In those situations where radiotherapy is to be considered as an alternative to limited or ablative surgery the argument is frequently and understandably advanced that the risks of regional metastases or general dissemination might be increased by leaving the tumour undisturbed for radiation treatment. In all tumour sites where radiotherapy has established itself as an acceptable alternative to surgery it has yet to be shown that patients receiving this treatment are at a greater metastatic risk than those undergoing surgery. It would appear that excisional surgery gives show the incidence ofcervical lymph node metastases, and distant metastases, and the distribution of the latter. The figures in these tables do not represent no greater immunity against local recurrence or individual patients, since one patient might show metastases than does radiotherapy, since in both metastases at more than one site. instances the behaviour of a given tumour depends It can be seen that cervical lymph node metastases on its inherent biological characteristics rather than developed during the course of the disease in seven the particular treatment administered. out of 59 (11-8%) of the cancerous melanosis cases. There is little information in the literature concern-None of the 15 cases of malignant change in a preing the incidence of regional and distant metastases cancerous melanosis developed nodes, while in the relative to the epibulbar malignant melanomata. malignant melanomata 11 out of 72 (15.3%) Reese3 mentioned that there was a 40% mortality developed nodes. among his cancerous melanosis patients but did not
The sites at which the 18 cases developed nodes specify the cause of death. Reese also advised elective was as follows: limbus, 6 cases; conjunctiva, 11 cases; radical neck dissection as part of the initial surgical lids, 1 case. With an overall metastatic node incidence treatment of cancerous melanosis, though the of 18 out of 146, that is, 12-7%, neither elective rationale and value of this procedure seem dissection nor irradiation of the clinically node-free uncertain.
neck would appear to be justified. Ophthalmic pathologists have not been able to add If one can speculate on these figures, it would seem greatly to our knowledge of the metastatic aspect of that cervical lymph node metastases as the only the natural history of these tumours. While tribute metastatic manifestation is uncommon, and when a 611 group.bmj.com on July 7, 2017 -Published by http://bjo.bmj.com/ Downloaded from patient does develop such metastatic nodes there is a high chance that more distant metastases may exist concomitantly.
In all the histological types where dissemination occurred the metastases were wide ranging in site with the chest, skin and intra-abdominal organs, and specially the liver affected.
The conjunctiva appears to be the primary site most frequently associated with metastases, but the limbus is noteworthy in the case of the malignant melanoma group.
REMOVAL OF THE EYE
Removal of the eye does not seem to influence materially the incidence of regional or Results of treatment
In the presentation of the results of radiation treatment of epibulbar malignant melanoma certain difficulties have to be borne in mind. These are:
(1) Current teaching and practice are based on the assumption that malignant melanomata are both highly malignant and radioresistant, and that ablative surgery is the treatment of choice. At one time Reese " considered cancerous melanosis to be the most malignant tumour encountered in ophthalmology, but later tempered2 this view in that, while still advocating exenteration as the treatment of choice, indications for lesser procedures such as partial excision with postoperative radiotherapy were accepted. However, irrespective of the nature of the operation performed routine elective neck dissection is advised.
(2) When dealing with a rare disease about whose natural history little is known and for which no certain remedy exists it is very easy to become a partisan of a given method oftreatment, particularly radiotherapy, which is without the mutilating consequence of surgery. In order to avoid this pitfall two (Table 9 ). Elective dissection or irradiation of the node-free neck was not practised. However, limited or radical dissection of the neck was performed on the 18 patients (Tables 5a and b ) who presented-with or developed cervical lymph node metastases. There were no survivors in this group.
Chemotherapy became available only during part ofthe period covered by this report and was employed without effect in eight cases. It can be seen from Tables 8a, b and c that of 50 cases primarily treated by radiotherapy 28 (56%) survived from one to 25 years, but 13 of the surviving patients lost the eye, several from radiation damage. With the five-year period of survival as the basis, 26 out of 35 patients (72.2%) have survived for a period of from five to 25 years, and of those survivors 14 (54%) have lost the eye. It would therefore seem that in nearly half the cases treated by radiotherapy it was possible both to control the disease and to save the eye.
The nine surgically treated cases are of interest as limited surgery was practised in most cases prior to referral without apparently worsening the prognosis. The results obtained in the group of patients suffering from precancerous melanosis undergoing malignant change are strikingly good (Table 9) (Figs.   1-5) . It is to be hoped that this can be attributed to the safety and wisdom of the observation policy adopted and also reflects the difference in natural history and prognosis of these lesions when compared with cancerous melanosis presenting without a precancerous phase. 
